Company profile: PharmaCord
1.1 - Company Overview
Company description
- Provider of patient support services for specialty medications, combining technology, personnel, and an on-site pharmacy to streamline prescriptions. Offers the PharmaCord Lynk platform for real-time patient status and insights, plus awareness, access (e.g., electronic prior authorizations, benefits verification), and affordability programs to help patients start and stay on therapy.
Products and services
- PharmaCord Lynk: A proprietary technology platform that connects all steps of the patient journey, delivering real-time patient status and insights to streamline access to therapies
- Patient Support Services: Technology-enabled program integrating personnel and an on-site pharmacy to streamline the prescription process for specialty medications, advancing efficient, rapid access to therapy
- Access Programs: Electronic access program that facilitates overcoming barriers to therapy, executing electronic prior authorizations and benefits verification to accelerate patients’ start on specialty medications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PharmaCord
Notable
HQ: United States
Website
- Description: Provider of an AI platform for healthcare operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Notable company profile →
Micro-Office Systems
HQ: United States
Website
- Description: Provider of cloud-based patient engagement and healthcare IT solutions, offering secure medical data migrations, legacy data archival/hosting, custom interfaces and hubs connecting EHRs and other systems, intelligent workflow automation with RPA, OCR/ICR and AI, and a Patient Communication Gateway to manage patient-provider communications across the patient lifecycle.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micro-Office Systems company profile →
Orthotaxy
HQ: France
Website
- Description: Provider of software-enabled surgery solutions for the healthcare industry, developing technologies designed to enhance patient benefits and outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Orthotaxy company profile →
Neagen
HQ: Finland
Website
- Description: Provider of medical imaging software for healthcare professionals, including neaLink VNA for DICOM archiving and interoperability; Digital Pathology for storing and viewing digital glass plates across scanners on PC and mobile; Radiology with enterprise imaging, AI and structured reporting; Operating Room AV integrating imaging devices with live streaming and storage to DICOM; Clinical Photos conversion to DICOM with archiving; and Digital ECG with real-time transfer and viewer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neagen company profile →
Irisnote
HQ: United States
Website
- Description: Provider of a scientific resource management platform that enables researchers to collaborate on data and information.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Irisnote company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PharmaCord
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PharmaCord
2.2 - Growth funds investing in similar companies to PharmaCord
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PharmaCord
4.2 - Public trading comparable groups for PharmaCord
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →